Skip to content

To explore the mechanism of acupuncture intervention on insulin resistance of phlegm-dampness polycystic ovary syndrome based on oxidative homeostasis

To explore the mechanism of acupuncture intervention on insulin resistance of phlegm-dampness polycystic ovary syndrome based on oxidative homeostasis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101096
Enrollment
Unknown
Registered
2025-04-21
Start date
2023-08-19
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome

Interventions

The metformin group:Start oral letrozole on the 3rd day of menstruation, 2.5 mg/day, continuously for 5 days. Instruct the patient to undergo dynamic monitoring of follicle development by ultrasound o
if =15mm, monitor daily until the follicle diameter is =18mm, defined as mature follicle. Administer 10,000 units of human chorionic gonadotropin (HCG) intramuscularly to induce follicle rupture post-
Acupuncture group:Start taking oral letrozole on the 3rd day of menstruation, 2.5 mg/day, for 5 consecutive days. Instruct the patient to undergo dynamic monitoring of follicle development by transvag
if =15mm, monitor daily until the follicle diameter is =18mm, defined as a mature follicle. Administer 10000 units of human chorionic gonadotropin (HCG) by intramuscular injection to induce follicle r

Sponsors

Fujian Maternal and Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Patients who meet the diagnostic criteria of Chinese and Western medicine; 2.Patients between the ages of 20 and 40 who have fertility requirements; 3.Patients with insulin resistance; 4.Those who voluntarily join and can perform regular visits.

Exclusion criteria

Exclusion criteria: 1.Patients with blood diseases, or with primary diseases such as liver, kidney, cardiovascular and cerebrovascular diseases, or mental diseases; 2.Exclude organic diseases or other endocrine disorders and other related diseases; 3. Patients who have taken hormone drugs such as ovulation stimulating drugs, glucocorticoids, contraceptives in the past 3 months, or have participated in other similar clinical trials; 4.Unable to complete the acupuncture treatment course, quit midway or lost visitors.

Design outcomes

Primary

MeasureTime frame
Six sex hormones;Anti-Müllerian Hormone;Blood Sugar;Oral glucose tolerance test;Insulin Release Test;Interleukin-6;Record pregnancy status.;

Secondary

MeasureTime frame
Cholesterol;Triglyceride;Low-density lipoprotein-C;Lipoprotein(a);High-density lipoprotein-C;Reactive Oxygen Species;Malondialdehyde;Nitric oxide;Total Antioxidant Status;Superoxide Dismutase;Glutathione peroxidase;Interleukin-2;Interleukin-10;Tumor Necrosis Factor-a;Traditional Chinese Medicine Symptom Score;Ovarian follicle development;Endometrial thickness on ovulation day;Blood flow in the uterine cavity;

Countries

China

Contacts

Public ContactYang Juan

Fujian Maternal and Child Health Care Hospital

yangjuan_5853629@163.com+86 158 8007 9502

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026